2010). Identification of natural product Fonsecin B as a stabilizing ligand of c-myc G-quadruplex DNA by high-throughput virtual screening. Chemical Communications, 46 (26), 4680-4682.
quadruplex DNA can be found throughout the human genome, particularly in the telomeres and in the promoter regions of growth control genes. 2 Notably, G-quadruplex promoter sequences have been identified for several proto-oncogenes, including c-myc, bcl-2, VEGF, KRAS, and c-kit. 3 Thus, there 20 has been an interest in the development of small molecule ligands that can stabilize specific promoter G-quadruplex DNA sequences. Examples include c-myc G-quadruplex DNA stabilization by cationic porphyrins, 3a,4 quindoline derivatives 5 and platinum complexes, 6 while isoalloxazines 7 and 25 triarylpyridine compounds 8 have been demonstrated to bind ckit G-quadruplex DNA.
Nature provides a wonderfully rich source of chemically diverse scaffolds for the medicinal chemist. 9 It is estimated that approximately 50% of all approved drugs in the years 30 2000-2006 were related to the natural products field in some way. 9a While the natural product telomestatin is the most potent G-quadruplex ligand known to date, 10 the majority of G-quadruplex binding ligands reported in the literature have been synthetic in origin. 11 Encouraged by the high molecular 35 diversity of natural products, and their potentially lower toxicity profiles compared to synthetic compounds, we sought to develop high-throughput, ligand docking-based virtual screening methods to identify small molecule leads from natural product databases. Using this computer-aided 40 approach, potent and specific ligands can be rapidly identified, potentially reducing the number of compounds that need to be evaluated in vitro. We have previously performed highthroughput virtual screening on a telomeric G-quadruplex DNA model to identify drug-like G-quadruplex ligands. 12 45 The nuclear hypersensitivity element III 1 (NHE III 1 ) is a guanine-rich 27 base-pair sequence located upstream of the cmyc P1 promoter, and controls 80-90% of c-myc transcription. 13 In order to develop a high-throughput screening platform for G-quadruplex binding ligands, a model 50 of the intramolecular G-quadruplex loop isomer of NHE III 1 was constructed using the X-ray crystal structure of the intramolecular human telomeric G-quadruplex DNA (PDB code: 1KF1). This NHE III 1 G-quadruplex isomer model has been previously employed to design quindoline compounds 55 that stabilize c-myc G-quadruplex DNA. 5 As part of our effort, the aforementioned model has been utilized in conjunction with in silico hit-to-lead optimization to develop new platinum(II) Schiff-base complexes with superior c-myc regulatory properties, presumably through stabilization of the 60 NHE III 1 G-quadruplex structure. 6 Using this approach, over 20,000 compounds in a natural product database 14 were screened in silico. The continuously flexible ligands were docked to a grid representation of the receptor and assigned a score reflecting the quality of the 65 complex according to the ICM method [ICM-Pro 3.6-1d molecular docking software (Molsoft)]. 15 The 5 highestscoring compounds (Fig. S1 †) were tested in a preliminary polymerase stop assay (vida infra) to assess their ability to stabilize the c-myc G-quadruplex, and fonsecin B (1) emerged 70 as the top candidate ( Fig. 1 ). Fonsecin B 1 is a naphthopyrone pigment originally isolated from the fungus Aspergillus fonsecaeus in 1974. 16a The related naphthopyrone fonsecin 16b,c (8-O-desmethyl 1) moderately inhibits interleukin-4 (IL-4) signal transduction, displaying IC 50 values of 30 μM and 34 75 μM against IL4-induced STAT6-driven gene transcription and germline Cε expression, respectively, whereas 1 itself showed no inhibition under the same conditions. 17 To the best of our knowledge, no G-quadruplex DNA-binding activity nor any other biological activity of fonsecin B 1 has been reported in 80 the literature.
The ability of 1 to interact with c-myc G-quadruplex DNA was first studied by an absorption titration experiment. An intramolecular c-myc G-quadruplex structure was prepared by incubating oligonucleotide Pu27 † in Tris/KCl buffer, which 85 was heated to 95 °C for 10 min and cooled to room temperature overnight. The expected G-quadruplex secondary DNA structure was confirmed by a positive CD peak at 262 nm and a negative CD peak at ca. 240 nm. Isosbestic spectral changes and hypochromic effects were observed in the UVvisible absorption spectral changes as depicted in Figure 2 . This hypochromic phenomenon is attributed to the strong interaction between fonsecin B 1 and G-quadruplex DNA.
Using the Scatchard equation, 18 the plot of D/∆ε ap vs D 5 revealed the binding constant K of 1 with G-quadruplex to be 1.1  10 6 dm 3 mol -1 at 20.0 °C. 19 To investigate the selectivity of 1 for G-quadruplex DNA over duplex DNA, a parallel UVvisible absorption titration experiment with calf thymus (ct) DNA was performed ( Fig. S2 †) . The K value for ct DNA was 10 calculated to be 2.0  10 5 dm 3 mol -1 , which is approximately 5.5-fold lower than the binding constant of 1 for the c-myc Gquadruplex. The binding constant of 1 for a random singlestranded 22-bp sequence SS22 † was similarly determined to be 6.9  10 4 dm 3 mol -1 ( Fig. S3 †) . Taken together, these data 15 reveal that fonsecin B 1 selectively binds c-myc G-quadruplex DNA over duplex and single-stranded DNA, with a 5.5-and 16.5-fold higher binding affinity, respectively, as determined from UV-visible absorption titration. We performed molecular modeling of fonsecin B 1 with the 20 NHE III 1 intramolecular G-quadruplex loop isomer model in order to further investigate the mode of binding. Hurley 20a and Patel 20b showed the predominance of the 1:2:1 loop isomer in the c-myc parallel G-quadruplex structure. Since neither NMR nor X-ray crystallographic information for the NHE III 1 1:2:1 25 loop isomer is available, a model was built from the known, closely related X-ray crystal structure of the human intramolecular telomeric G-quadruplex DNA. A truncated 18 base-pair sequence [5′-AGGGTGGGGAGGGTGGGG-3′] was used for this work since nucleotides G2-G5 in the c-myc 30 sequence [5′-TGGGGAGGGTGGGGAGGGTGGGGAAGG-3′] are not involved in the G-quartet structure. The molecular docking results show that 1 binds strongly to c-myc Gquadruplex DNA with a binding energy of -47.88 kcal mol -1 , and that the relatively flat scaffold of 1 is stacked on the ends 35 of the G-quadruplex at the 3′-terminus ( Figure 3 ). Interestingly, in this model the phenolic and carbonyl oxygen atoms of 1 are situated close (4.8-5.1 Å) to a potassium ion in the central channel of the G-quadruplex, possible contributing favourable electrostatic interactions to the binding score. The 40 binding energies for intercalation (ca. 25 kcal mol -1 ) are markedly higher, suggesting that fonsecin B 1 is unlikely to bind c-myc G-quadruplex DNA through an intercalative binding mode. Stacking near the 5′-terminal (-36.49 kcal mol -1 ) is also predicted to be disfavoured relative to 3′-end 45 stacking (Table S1 †).
To validate our molecular modeling results, a dose response experiment with 1 was performed using the polymerase stop assay. In this assay, fonsecin B 1 was incubated with oligomer Pu27 in the presence of Taq polymerase. Formation of the 50 intramolecular G-quadruplex prevents DNA annealing and subsequent Taq polymerase-mediated DNA extension. This is manifested as a reduction in the 43 bp PCR product observed after agarose gel electrophoresis. The results show that the addition of fonsecin B 1 led to a dose-dependent decrease in 55 the 43 bp PCR product, with complete inhibition observed at , [year], , 00-00 | 83 M of 1 (Figure 4 ). The IC 50 value of 1 against Taq polymerase-mediated DNA amplification due to stabilization of the c-myc G-quadruplex is estimated to be approximately 20 M. To confirm the impact of fonsecin B 1 on c-myc Gquadruplex stabilization, a parallel experiment using oligomer 5 Pu27m † was performed. This oligonucleotide is unable to form the G-quadruplex structure. Under the same reaction conditions, no inhibition was observed (data not shown). Importantly, fonsecin B 1 displayed comparable potency to the well-known G-quadruplex binder TMPyP4 3a under the 10 same experimental conditions (Fig. S4 †) . We envisage that this natural product scaffold may serve as a useful template for future lead optimization studies.
In conclusion, this intramolecular G-quadruplex NHE III 1 loop isomer model, constructed using the X-ray crystal 15 structure of the intramolecular human telomeric G-quadruplex DNA, is a unique model developed by our group that has been successfully validated in previous reports. We have utilized this model in the present study to perform high-throughput virtual screening on a natural product library of over 20,000 20 compounds. Fonsecin B 1 emerged as the top candidate and was demonstrated to inhibit Taq-mediated extension through stabilization of the G-quadruplex secondary structure (IC 50 = ca. 20 M), with potency comparable to TMPyP4. 21 To our knowledge, this is the first large-scale application of high- 25 throughput virtual screening of a natural product database for c-myc G-quadruplex stabilizing ligands. Computer-based hitto-lead optimization is currently being carried out in order to generate further analogues for in vitro testing. 
Experimental section
Materials. Calf thymus DNA (ct DNA) was purchased from Sigma Chemical Co. Ltd. and purified by the literature method. 1a The DNA per base pair concentration was determined by UV/Vis absorption spectroscopy using the following molar extinction coefficients at the indicated wavelengths: calf thymus DNA,  260 = 13200 bp cm -1 M -1 (base pair). 1b DNA oligomers were obtained from Tech Dragon Limited (Carlsbad, CA). The sequences for oligomers Pu27, Pu27m and SS22 are:
Fonsecin B 1 and the other tested compounds was obtained from Analyticon Discovery GmbH (Postdam, Germany). 1 was obtained in 96% purity by HPLC-ELSD (Fig. S5 †) . This database, containing over 20,000 natural product/natural product-like structures, is publicly available and can be accessed free of charge. Unless otherwise stated, spectroscopic titration experiments were performed in 10 mM Tris/HCl (pH 7.5) containing 100 mM KCl. Taq DNA polymerase was purchased from QIAGEN (Valencia, CA). Stock solution of 1 (10 mM) was made in dimethyl sulfoxide (DMSO). Further dilutions to working concentrations were made with double-distilled water.
Physical measurement. Absorption spectra were recorded on a Perkin-Elmer Lambda 19 UV/Visible spectrophotometer. 
where D is the concentration of DNA, Δε ap = |ε A ε F |, ε A = A obs /[ligand], and Δε = |ε B ε F |; ε B and ε F correspond to the extinction coefficients of DNAligand adduct and unbound ligand, respectively. A similar absorption titration experiment was performed using ct DNA (0-24 μM) and SS22 (0-99 μM).
Polymerase stop assay. The polymerase stop assay was performed by using a modified protocol of the previously reported method. 3 The reactions were performed in 1 PCR buffer, containing each pair of oligomers (10 mmol), deoxynucleotide triphosphate (0.16 mM), Taq polymerase (2.5 U), and increasing concentrations of the fonsecin B 1 (from 0.3 to 250 M). The reaction mixtures were incubated in a thermocycler under the following cycling conditions: 94 °C for 3 min followed by 30 cycles of 94 °C for 30 s, 58 °C for 30 s, and 72 °C for 30 s. The amplified products were resolved on 1.3% agarose gel and visualized by ethidium bromide staining.
Molecular modeling. Molecular docking was performed by using the ICM-Pro 3.6-1d program (Molsoft). 4 According to the ICM method, the molecular system was described by using internal coordinates as variables. Energy calculations were based on the ECEPP/3 force field with a distance-dependent dielectric constant. The biased probability Monte Carlo (BPMC) minimization procedure was used for globalenergy optimization. The BPMC global-energy-optimization method consists of 1) a random conformation change of the free variables according to a predefined continuous probability distribution; 2) local-energy minimization of analytical differentiable terms; 3) calculation of the complete energy including nondifferentiable terms such as entropy and solvation energy; 4) acceptance or rejection of the total energy based on the Metropolis criterion and return to step (1). The binding between 1 and DNA was evaluated by binding energy, including grid energy, continuum electrostatic, and entropy terms. The initial model of loop isomer was built from the X-ray crystal structures of human intramolecular telomeric G quadruplex (PDB code: 1KF1), 5 according to a previously reported procedure. 3, 6 Briefly, the structure of human intramolecular telomeric G quadruplex was imported into Insight II package (Accelrys Inc., San Diego, CA), and necessary modifications were carried out including replacements and deletions of bases. Missing loop nucleotides were added using single-strand B-DNA geometry using the Biopolymer module. Potassium ions were placed between the G-tetrad planes to stabilize the tetrad structure. The initial models were then immersed in a box of TIP3P water molecules, and an appropriate number of sodium ions was added to neutralize the negative charge of the phosphate backbone. The molecular dynamics simulations were carried out in NAMD with VMD monitoring the process. The CHARMM force field parameter was assigned to every atom, and the Particle Mesh Ewald electrostatics was used to compute long-range electrostatic interactions. Hydrogen atoms were added and minimized by 3000 steps of conjugate gradient minimization. After 4000 steps of conjugate gradient minimization, two stages of molecular dynamics simulations were carried out at 300 K. In the first stage, only the loop area atoms were allowed to move, and this process involved a 20 ps equilibration and 100 ps simulations. The second stage involved unrestrained molecular dynamics simulations with 20 ps equilibration and 100 ps simulations at 300 K. Trajectories were recorded every 0.1 ps, and the most stable structure was extracted and further refined by 2500 steps of conjugate gradient minimization. In the docking analysis, the binding site was assigned across the entire structure of the DNA molecule. The ICM docking was performed to find the most favorable orientation. The resulting trajectories of the complex between 1 and G-quadruplex DNA were energy minimized, and the interaction energies were computed. Table S1 . Calculated binding energies (in kcal/mol) for 1 bound to different sites of the intramolecular c-myc G-quadruplex.
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